4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
3.235
-0.105 (-3.14%)
Apr 29, 2025, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $149.79 million as of April 29, 2025. Its market cap has decreased by -89.43% in one year.
Market Cap
149.79M
Enterprise Value
-331.30M
1-Year Change
-89.43%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $149.79M, a decrease of -74.19%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 154.65M | -39.94% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |